What is Hims Stock and what does NYSE: HIMS represent?
Hims stock refers to the publicly traded shares of Hims & Hers Health, Inc., a consumer-focused telehealth company that lists on the New York Stock Exchange under the ticker HIMS, commonly written as NYSE: HIMS. When people talk about “buying Hims stock,” they are usually referring to Class A common shares of this company, which give holders an ownership stake in the business and expose them to the price movements of the shares.
This page is an independent, educational overview. It is not affiliated with Hims & Hers, and it is not investment advice. Nothing here recommends buying, selling, or holding any security. The goal is simply to help you understand what Hims stock is, how the company reached the public market, what tends to move the share price, and where to find reliable, live data.
Hims & Hers operates a subscription-based platform that connects consumers with licensed providers and ships prescription and over-the-counter products for categories such as sexual health, dermatology, mental health, hair loss, and weight management. For a broader look at the company itself rather than the stock, see our overview of Hims and Hers. Understanding the business model matters, because the share price ultimately reflects investor expectations about how that business will perform over time.
How did Hims & Hers go public?
Hims & Hers became a publicly traded company in January 2021 through a merger with a special purpose acquisition company (SPAC) known as Oaktree Acquisition Corp. This is different from a traditional initial public offering (IPO). In a SPAC merger, a shell company that is already listed raises money and then combines with a private operating company, which effectively takes the listed company’s place on the exchange.
The SPAC route was a popular path to the public markets for high-growth consumer and technology companies during 2020 and 2021. After the merger closed, the combined entity traded under the HIMS ticker. It is worth remembering that companies which go public via SPAC can have different early-trading dynamics than those that list through a conventional IPO, including different lock-up structures and share counts. If you want to understand the historical share structure in detail, official filings with the U.S. Securities and Exchange Commission (SEC) are the primary source.
What drives the Hims share price?
No single factor determines where Hims stock trades. Instead, the price reflects a shifting blend of company performance, investor sentiment, and external news. Broadly, the most-watched drivers include:
- Revenue growth: As a high-growth company, Hims & Hers is often judged on how quickly its top line expands quarter over quarter and year over year.
- Subscriber counts: The subscription model means the number of paying subscribers, and how much each one spends, is a closely followed indicator of momentum.
- Gross margins and profitability: Investors watch whether the company can grow while improving margins and moving toward or sustaining profitability.
- Forward guidance: Management’s outlook for future revenue and earnings can move the stock as much as, or more than, reported results.
- The GLP-1 and weight-loss category: Growth in the weight-management business, including GLP-1-related offerings, has been a notable theme. See our Hims Weight Loss overview for context on that category.
- Regulatory and partnership news: Developments involving compounded medications, relationships with drug manufacturers such as Novo Nordisk, and the broader regulatory environment have historically prompted sharp moves.
Because these drivers interact, the stock can react strongly to a single headline even when the underlying business changes only modestly. That sensitivity is part of what makes HIMS a stock that active investors tend to monitor closely.
Why has Hims stock been volatile?
Historically, HIMS has been a volatile stock. Large percentage swings have often clustered around quarterly earnings reports and around news related to the GLP-1 weight-loss category and regulatory matters. This pattern is common among high-growth companies whose valuations depend heavily on future expectations rather than current cash flows.
Several structural factors contribute to that volatility. First, growth stocks are valued largely on projected future performance, so any change in the growth outlook can produce an outsized price reaction. Second, the weight-loss category has been fast-moving and subject to regulatory attention, which introduces headline risk. Third, elevated short interest, which we discuss on our Hims Short Interest page, can amplify moves in both directions.
Volatility cuts both ways: it can mean sharp gains as well as steep declines. Importantly, past volatility does not predict future price behavior, and a stock that has moved sharply in the past will not necessarily continue to do so. This is one reason many educational resources emphasize risk management and diversification, though none of that is a recommendation.
What key metrics do investors watch for HIMS?
Investors and analysts tend to focus on a recurring set of metrics when they evaluate Hims stock. The table below summarizes some of the most commonly cited ones. These descriptions are general and educational; any specific figures you encounter should be treated as last-known or illustrative rather than live, and confirmed against current filings or a market data source.
| Metric | What it indicates | Where to verify |
|---|---|---|
| Revenue growth | Pace of top-line expansion | Quarterly earnings releases, SEC filings |
| Subscriber count | Size and momentum of the subscription base | Company earnings materials |
| Average revenue per subscriber | Monetization per customer | Company earnings materials |
| Gross margin | Profitability of core operations | Income statement in filings |
| Adjusted EBITDA / net income | Overall profitability trend | Earnings releases, SEC filings |
| Forward guidance | Management’s expectations | Earnings calls and press releases |
| Short interest | Bearish positioning in the stock | Exchange and short-interest data providers |
For a deeper look at how the company reports these numbers and when, see our Hims Earnings page. Note that reported figures are point-in-time; the meaning investors assign to them evolves as expectations shift.
How do analysts and forecasts fit in?
Analysts who cover Hims stock publish price targets, ratings, and models that project future revenue and earnings. These forecasts can influence sentiment, but they are opinions, not guarantees, and they frequently disagree with one another. A range of bullish and bearish views usually exists for any actively followed growth stock, and consensus estimates can change quickly after new information.
Our Hims Stock Forecast page explains how these forecasts are constructed and how to think about bull-case versus bear-case scenarios without treating any of them as a prediction you should act on. The key takeaway for this overview is simple: forecasts are inputs to your own research, not substitutes for it, and reasonable analysts can reach very different conclusions from the same facts.
How can you follow Hims news and developments?
Because news moves HIMS, staying informed matters for anyone studying the stock. The kinds of developments that have historically affected the share price include earnings results and guidance, regulatory news around the weight-loss and GLP-1 category, partnerships or supply relationships, product launches, and broader shifts in sentiment toward telehealth and growth stocks.
Reliable ways to follow these developments include the company’s official investor relations page, SEC filings, reputable financial news outlets, and market data platforms. Our Hims News page discusses the categories of news that tend to matter and how to interpret them without overreacting to any single headline. Be cautious with social media chatter, which can be noisy and occasionally misleading.
Where should you track the current Hims stock price?
This page intentionally does not display a live or current price, and any figures mentioned in our content should be read as historical or illustrative rather than up to date. Stock prices, market capitalization, and valuation multiples change constantly during trading hours, and a number that was accurate yesterday may be stale today.
To see the current HIMS quote, use a real-time source such as your brokerage account, the NYSE website, or a major financial data provider. When you do, keep in mind that some free quote sources are delayed by several minutes. For official corporate information, filings, and shareholder materials, the company’s investor relations site and the SEC’s EDGAR database are authoritative primary sources.
What are the main risks to understand?
Every stock carries risk, and Hims stock is no exception. Understanding the general categories of risk is part of being an informed reader, though none of the following is a recommendation or a prediction.
- Regulatory risk: Changes in rules affecting telehealth, prescribing, or compounded medications could affect the business.
- Competitive risk: The consumer-health and weight-loss markets are competitive and evolving.
- Concentration risk: Heavy reliance on a fast-growing category can cut both ways if that category slows or faces new constraints.
- Valuation risk: High-growth stocks priced on future expectations can fall sharply if growth disappoints.
- Market risk: Broad market moves and shifts in sentiment toward growth stocks affect HIMS regardless of company-specific news.
These risks are illustrative and not exhaustive. A full understanding requires reading the company’s own risk disclosures in its SEC filings, which detail the factors management considers material.
How should a beginner approach researching Hims stock?
If you are new to researching a stock like HIMS, a measured approach tends to serve better than reacting to headlines. Start with primary sources: read the company’s most recent earnings release and its annual and quarterly filings to understand the business in the company’s own words. Then look at how the reported metrics have trended over several quarters rather than focusing on a single data point.
From there, you can layer in secondary perspectives, such as analyst commentary and reputable news coverage, while remembering that these are opinions. Finally, place any single stock in the context of your own overall financial situation, time horizon, and risk tolerance. Many educational resources suggest that concentrated positions in volatile growth stocks warrant particular care, though how you act on that is a personal decision best discussed with a licensed professional.
To go deeper on specific topics, explore our related pages on Hims Earnings, the Hims Stock Forecast, Hims Short Interest, and Hims News. Each builds on the foundation covered here.
A note on independence and accuracy
Hims Guide is an independent, informational resource. We are not Hims & Hers, we are not a broker or financial adviser, and we do not sell securities or execute trades. Everything on this page is general educational information, not investment advice, and it should not be relied upon as the basis for any transaction.
We aim to be factually careful, but company details, share structures, and market data change over time. Where this page describes facts about the company, treat them as accurate to the best of our knowledge as of the publication date and verify anything material against primary sources such as SEC filings and the company’s investor relations site. For prices and other live figures, always use a real-time market data source rather than this page.